TORONTO, September 2018 – Echelon Wealth Partners Inc. (Echelon) acted as the exclusive financial advisor to Emblem Corp. (Emblem, EMC-TSXV) through its wholly-owned subsidiary Emblem Cannabis Corporation in respect to a signed supply agreement with Aphria Inc. (Aphria, APH-TSX). The agreement will see Emblem purchase 175,000 kg equivalents of cannabis products from Aphria over a five-year term with the option for five-year renewals. The deal represents the largest Canadian cannabis supply agreement upon its signing.
As part of the deal, Emblem will pay Aphria $12,755,625 as an initial cash deposit and provide the issuance of 6,952,169 common shares of Emblem. The supply of dried flower and crude cannabis oil will commence in April 2019 with it being processed at Emblem’s Paris, Ontario facility.
“Emblem’s supply agreement with Aphria marks a critical point in our evolution. It allows Emblem to remain focused on strengthening our core competencies of product innovation, brand building and securing distribution,” said Nick Dean, CEO, Emblem Corp. “Aphria’s support solidifies Emblem’s dedication to become a leading producer of cannabis-derived products in the health and wellness space.”
Echelon’s Peter Graham, Vice President, Investment Banking, Special Situations felt “this supply agreement was a natural fit for both Aphria and Emblem, and underscores Emblems focus on products, brands and distribution across the cannabis space. This landmark supply agreement illustrates the value Echelon brings to the table as a strategic and financial advisor for industry stakeholders.”
With multiple previous deals in the cannabis industry, Echelon has become one of the largest recognized brokerage firms providing financing and advisory services in this growing industry including deals with Green Thumb Industries Inc. (GTII-CNSX), CannTrust Holdings Inc. (TRST-TSX), MPX Bioceuticals Corp (MPX-CSE) and others. Echelon will continue to provide expert research, advice and financing services as the industry changes through recreational legalization.
Emblem, through its wholly-owned subsidiary Emblem Cannabis Corporation, is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Emblem’s state-of-the-art indoor cannabis cultivation facility and research and development laboratory is located in Paris, Ontario. Led by an experienced management team of healthcare executives, accomplished marketing professionals, and cannabis experts, Emblem is focused on driving shareholder value through product innovation, brand relevance, and access to patient and consumer channels. Emblem is also the parent company of GrowWise Health Limited, one of Canada’s leading cannabis education services. Emblem trades under the ticker symbol EMC on the TSX Venture Exchange.
Echelon Wealth Partners Inc. is a Canadian independent wealth management and capital markets firm known for its client-centred approach and innovative, entrepreneurial spirit. The company has approximately 60 Advisor and Portfolio Manager Teams with more than $6 billion in assets under administration and management. Echelon offers a wide range of financial services for individuals, households, institutions and corporate clients from its offices in Toronto, Oakville, Ottawa, London, Montreal, Saskatoon, Calgary, Edmonton, Vancouver and Victoria. Echelon Wealth Partners is a member firm of the Investment Industry Regulatory Organization of Canada (IIROC) and a member of the Canadian Investor Protection Fund (CIPF). For more information, please visit www.echelonpartners.com.
For more information, media may contact:
Chief Strategy Officer
Echelon Wealth Partners